MedImmune and NGM Biopharmaceuticals announce agreement
17 June 2013 | By AstraZeneca
MedImmune and NGM Biopharmaceuticals have entered into an exclusive agreement...
List view / Grid view
News
Three Scientists to receive prestigious Novartis Prizes for Immunology at 15th International Congress of Immunology
17 June 2013 | By Novartis
The Novartis Prizes for Immunology are awarded to three scientists...
Roche’s Avastin approved in Japan for treatment of the most aggressive form of brain cancer
17 June 2013 | By Roche
First approval of Avastin for the treatment of newly diagnosed glioblastoma...
Drug Jakavi® improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease
16 June 2013 | By Novartis
Results from a Phase III three-year follow-up study...
FDA approves Amgen’s XGEVA® (denosumab) for the treatment of giant cell tumor of bone
13 June 2013 | By Amgen
XGEVA becomes first FDA-approved treatment for this rare disease...
Boehringer Ingelheim’s investigational all-oral interferon-free combination achieved 95% viral cure rates in genotype-1b hepatitis C patients
13 June 2013 | By Boehringer Ingelheim
Data from interferon-free SOUND-C3 study...
Roche’s RoACTEMRA shows long-term efficacy in monotherapy and also benefits in early rheumatoid arthritis
13 June 2013 | By Roche
Roche announced data from two phase III studies...
bioMérieux Industry celebrates the 10th anniversary of BioBall®
12 June 2013 | By bioMérieux
A wide range of BioBall® products to meet diverse customer needs...
Amgen announces top-line results of Phase 3 Trebananib (AMG 386) TRINOVA-1 trial in recurrent ovarian cancer
12 June 2013 | By Amgen
Study meets primary endpoint of progression-free survival...
Amgen and Cytokinetics announce expansion of license for Omecamtiv Mecarbil
12 June 2013 | By Amgen
Amgen and Cytokinetics announced an expansion of their strategic collaboration...
Merck welcomes independent review of the safety profile of JANUVIA® (sitagliptin)
12 June 2013 | By Merck
"Nothing is more important to Merck than the safety of our medicines..."
AbbVie presents first study assessing the role of predefined doses of methotrexate when used in combination with HUMIRA® (adalimumab) for RA
12 June 2013 | By AbbVie
Results from the CONCERTO trial...
Abbott initiates randomized clinical trial in Japan to evaluate the Absorb™ Bioresorbable Vascular Scaffold
11 June 2013 | By Abbott
Trial to study the innovative "dissolving" heart device...
New four-strain influenza vaccine from Sanofi Pasteur now licensed by FDA for broad age range of children and adults
10 June 2013 | By Sanofi Pasteur
“Sanofi Pasteur is committed to providing new immunization options..."
Roche’s RoACTEMRA approved in EU to treat children with rare form of arthritis
10 June 2013 | By Roche
“This approval comes earlier than expected, just one month following the positive CHMP opinion...”
